Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders. Curculigoside can promote calcium deposition and increase the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character. Curculigoside possesses potent antioxidant properties against oxidative stress insults. can protect endothelial cells against oxidative injury induced by H2O2, suggesting that this compound may constitute a promising intervention against cardiovascular disorders.
Product Specifications
CAS Number
85643-19-2
Product Name Alternative
Curculigoside A | Curculigoside-A
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 100 mg/mL (214.39 mM)
Smiles
COC1=C (C (=CC=C1) OC) C (=O) OCC2=C (C=CC (=C2) O) OC3C (C (C (C (O3) CO) O) O) O
Molecular Formula
C22H26O11
Molecular Weight
466.43
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
[5-Hydroxy-2-[ (2S,3R,4S,5S,6R) -3,4,5-trihydroxy-6- (hydroxymethyl) oxan-2-yl]oxyphenyl]methyl 2,6-dimethoxybenzoate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CCNI, CT (CCNI, Cyclin-I) (Biotin) discontinued
UGT2A3, ID (UGT2A3, UDP-glucuronosyltransferase 2A3) (MaxLight 750)